Stay updated on BI 655130 Dosing in Palmoplantar Pustulosis Clinical Trial
Sign up to get notified when there's something new on the BI 655130 Dosing in Palmoplantar Pustulosis Clinical Trial page.

Latest updates to the BI 655130 Dosing in Palmoplantar Pustulosis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe study locations section was expanded to show detailed site listings across multiple US states (Alabama, California, Georgia, Kansas, Missouri, Nebraska, New Jersey, Pennsylvania, Texas, Utah, Virginia) and international regions (Australia: ACT, NSW, Queensland, Victoria; Canada: Alberta, New Brunswick, Ontario, Quebec). The page also removed the HHS Vulnerability Disclosure link and updated to revision v3.3.3.SummaryDifference1%

- Check25 days agoNo Change Detected
- Check40 days agoChange DetectedPublication note in the PubMed section was updated to say publications are automatically filled in from PubMed. The page revision is updated to v3.3.2 (replacing v3.2.0).SummaryDifference0.1%

- Check47 days agoChange DetectedA temporary government funding status notice was removed. The page's study details, eligibility criteria, and outcome measures remain unchanged.SummaryDifference0.2%

- Check69 days agoChange DetectedNo significant changes detected; core study details and endpoints appear unchanged.SummaryDifference0.3%

- Check76 days agoChange DetectedNew content adds Paratus Clinical Research Woden and an updated data-sharing scope for Boehringer Ingelheim studies; older, more specific IPD sharing details and access criteria from 2022-era text have been removed.SummaryDifference8%

- Check90 days agoChange DetectedAdded a government-operation status notice and link details plus a version bump to v3.2.0; removed the previous v3.1.0 reference.SummaryDifference2%

Stay in the know with updates to BI 655130 Dosing in Palmoplantar Pustulosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 655130 Dosing in Palmoplantar Pustulosis Clinical Trial page.